Key facts
- This page summarizes Stavros G. Vizirgianakis's Form 4 filing for Bioventus Inc. (BVS).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2022, 20:42.
Stavros G. Vizirgianakis - 16 Jun 2022 Form 4 Insider Report for Bioventus Inc. (BVS)
- Reporting relationship
- Director
- Issuer ticker
- BVS
- Reported as of
- 16 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Jun 2022, 20:42:47 UTC
- Prior SEC filing
- 08 Dec 2021
- Next SEC filing
- 26 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anthony D'Adamio, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stavros G. Vizirgianakis filed Form 4 for Bioventus Inc. (BVS) on 22 Jun 2022.
Change
- Previous filing in this sequence was filed on 08 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BVS
transaction
Class A common stock
Options Exercise
- Transaction value
- $0
- Shares
- +965
- Change %
- +0.03%
- Price
- $0.000000
- Shares after
- 2,781,888
- Date
- 16 Jun 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BVS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -965
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 1,930
- Date
- 16 Jun 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 965
- Exercise price
- Footnotes
- F1, F2
BVS
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +16,648
- Change %
- Price
- $0.000000
- Shares after
- 16,648
- Date
- 17 Jun 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 16,648
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Footnote F2
The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Footnote F3
The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.